atients with chronic illnesses such as infections and malignancies are often confronted with cachexia, a multifactorial syndrome that aggravates the underlying disease and worsens prognosis 1, 2 . Cachexia manifests with both behavioral and metabolic symptoms, the severity of which varies between diseases and individuals, making it difficult to define and diagnose 3, 4 . Cachectic patients exhibit anorexia, anhedonia and lethargy, as well as unintentional loss of over 5% of their body weight 3, 4 . This is caused by a rapid depletion of fat and lean mass, which not only impacts the patient's quality of life, but is also often a leading cause of morbidity and mortality 2, 3, 5 . Conventional nutritional support does not reverse cachexia. Although several treatment options such as agonists for the orexigenic hormone ghrelin are explored, standards of care to prevent or alleviate cachexia remain ill-defined 1, 6 . The emergence of cachexia accompanies a surge of proinflammatory cytokines such as tumor necrosis factor (TNF), interferon (IFN)-γ, interleukin (IL)-6 and IL-1 7, 8 . Depending on the disease model, these cytokines can be secreted by tumor cells, in the case of cancer, host immune cells and/or cells involved in metabolic regulation, such as adipocytes 9, 10 . Murine models of cancer-associated cachexia (CAC) have greatly improved our understanding of the mechanisms contributing to weight loss 5, 10, 11 . However, appropriate mechanistic models to study cachexia in the context of infection are still underdeveloped. In the present study we employed a murine benchmark model of chronic viral infection to interrogate the molecular and cellular requirements for infection-associated cachexia (IAC). We designed an integrative approach of genetic, dietary and pharmacologic perturbations to uncover both the shared and the unique properties of CAC and IAC. This led to the characterization of morphologic, molecular and metabolic changes in adipose tissue, and identified the main immune drivers of IAC, providing much-needed molecular insights into the pathophysiology of cachexia.
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Results
Infection with LCMV clone 13 leads to reversible cachexia. Wildtype C57BL/6J mice infected with 2 × 10 6 focus forming units (FFU) of the chronic strain clone 13 of the lymphocytic choriomeningitis virus (LCMV) exhibited 15-20% weight loss within the first week of infection (Fig. 1a) . To assess whether this is a manifestation of cachexia or a direct result of anorexia, we fed uninfected, wild-type mice with the same amount of chow diet consumed by LCMV-infected mice for 2 weeks post-infection (pair feeding). Between 6 and 8 days after infection the pair-fed, uninfected group lost less than 3% of the initial weight compared with over 10% lost by infected mice (Fig. 1a,b) , indicating that the anorectic feeding behavior could not account for the full extent of weight loss observed in the LCMV-infected mice. To characterize the infection-induced pathophysiology, we used metabolic cages to monitor LCMV-infected mice compared with age-and sex-matched uninfected mice. Between day 6 and day 8 after infection, mice exhibited signs of lethargy and showed reduced food and water intake, activity and energy expenditure compared with uninfected mice (Fig. 1b-d and Supplementary Fig. 1a ). The respiratory exchange ratio (RER), calculated from the ratio of CO 2 emission to O 2 consumption, showed a significant reduction between day 6 and day 8 post-infection ( Fig. 1d and Supplementary Fig. 1a ), suggesting that LCMV-infected mice relied on fat metabolism as the main energy
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Percentage of initial body weight (g) FFU of LCMV clone 13, compared with pair-fed (PF) mice (n = 5). b,c, Food intake (b) and water intake (c) of LCMV-infected mice compared with uninfected controls (n = 10; ****P < 0.0001, two-way analysis of variance (ANOVA)); data are representative of three independent experiments for a and b, and c represents a single experiment. d, Activity, oxygen consumption and RER in LCMV-infected mice compared with uninfected controls (Ctrl; n = 10). Data shown represent the average of days 6, 7 and 8 post-infection (****P < 0.0001) from a single experiment. e, Percentage of tissue weight normalized to body weight before infection in inguinal, gonadal and interscapular brown adipose tissue (**P = 0.002, ***P = 0.0006, *P = 0.0172, ***P = 0.0009, unpaired, two-tailed, Student's t-test), as well as quadriceps (M.quadr.), gastrocnemius (M.gastr.) and soleus (M.sole.; *P = 0.039, **P = 0.0035, ***P = 0.0001, unpaired, two-tailed, Student's t-test) at day 7 for pair-fed uninfected mice and days 6 and 8 post-infection for LCMV-infected mice (n = 5). BAT, brown adipose tissue; iWAT, inguinal white adipose tissue; gWAT, gonadal white adipose tissue. f, Body composition as measured in live, un-anesthetized, LCMV-infected mice using EchoMRI (n = 5). e,f, Representative data of two independent experiments. g, Body weight kinetics in LCMV-infected mice supplemented with the equivalent of 1 kcal of indicated diet through oral gavage daily between day 4 and day 7 post-infection (n = 4; ***P = 0.0003, twoway ANOVA, Bonferroni's correction). Data are representative of three independent experiments. All data show the mean ± s.e.m.
substrate. These pathophysiologic changes preceded the peak of the viral load and of the adaptive immune response, which happened at days 8-12 (see Supplementary Fig. 1b-d) . After day 8 mice slowly started to regain weight, despite the continuous presence of the virus (Fig. 1a-c and Supplementary Fig. 1a-d) 
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. By comparing the body composition, we found that both the fat and the lean (muscle) masses were severely depleted in the first week after infection compared with the pair-fed, uninfected mice (Fig. 1e,f) . The fat tissue, however, underwent an earlier and more severe depletion compared with muscles, starting 4 days post-infection (Fig. 1f) . This depletion over time affected different fat depots, including the inguinal white adipose tissue, gonadal white adipose tissue and interscapular brown adipose tissue (Fig. 1e) . To assess the loss of muscle mass we examined quadriceps, gastrocnemius and soleus, which represent both slow-and fast-twitch muscles. The muscle mass of quadriceps and gastrocnemius was reduced in infected mice compared with pair-fed mice (Fig. 1e) . This was associated with decreased expression of the myoblast differentiation marker, MyoD1, and the increased expression of Fbxo32 and Trim63, encoding Atrogin1 and Murf1, respectively, involved in proteasomal degradation in all three muscles in the infected mice compared with pair-fed mice (see Supplementary Fig. 1e-g ).
To evaluate the relationship between the viral inoculum and the weight loss, we titrated the infection dose of LCMV clone 13, ranging from 2 × 10 6 FFU to 2 × 10 2 FFU. There was a marked amelioration of weight loss at the lower virus inocula; doses below 2 × 10 4 FFU showed little to no weight loss (see Supplementary Fig. 1h ). These lower virus inocula are known to be associated with accelerated viral clearance 13 . Infection with the acute strain of LCMV resulted in similar weight kinetics to low-dose LCMV clone 13 infection (see Supplementary Fig. 1i ), suggesting a possible link between determinants for viral persistence and the development of cachexia.
To examine whether weight loss was ameliorated by nutrient supplementation, we used oral gavage to administer a daily caloric intake of 1 kcal of a chow-like control diet, glucose, olive oil or casein to LCMV clone 13-infected mice between day 4 and day 8 post-infection. Oral gavage supplementation did not alleviate weight loss compared with the PBS-supplemented control (Fig. 1i) . On the contrary, all gavage-supplemented groups recovered at a slower rate compared with PBS-supplemented, LCMV-infected mice (see Supplementary Fig. 1j ), indicating that virus-induced weight loss cannot be prevented by nutritional supplementation. These results reveal several hallmarks of cachexia in LCMV clone 13-infected mice, including anorexia and metabolic dysfunction, as well as depleted fat and muscle mass that cannot be reversed by nutritional supplementation.
Viral infection triggers adipose tissue remodeling and lipolysis.
Both subcutaneous and visceral compartments of the adipose tissue in LCMV-infected mice underwent depletion compared with uninfected controls (Fig. 2a) . Using histologic analysis to examine the morphologic changes in the inguinal adipose tissue of LCMVinfected compared with uninfected mice, we observed a significant reduction in the size of adipocytes at days 6 and 8 post-infection (Fig. 2b,c) . Next, we determined the protein abundance and activation status of adipose triglyceride lipase (ATGL) and hormonesensitive lipase (HSL), two enzymes central to lipolysis 14 , in inguinal adipose tissue at days 0, 4, 6 and 8 after LCMV infection. Expression of ATGL and HSL, as well as that of phosphorylated-HSL (pHSL), phosphorylated at residue Ser 660 , were increased in inguinal adipose tissue during LCMV infection compared with uninfected mice (Fig. 2d) , suggesting increased lipolysis peaking at day 6 post-infection. This was corroborated by elevated levels of non-esterified fatty acids (NEFAs) in the serum of LCMV-infected mice compared with uninfected controls (Fig. 2e) . In addition, reduced messenger RNA expression of the lipoprotein lipase (Lpl) and, to a lesser extent, of the lipid-scavenging receptor Cd36 in inguinal fat, together with the increased levels of triglyceride in the serum of LCMV-infected mice compared with pair-fed uninfected mice (Fig. 2e,f) , indicated a reduction in the rate of lipid uptake in adipose tissue and/or lipid mobilization in the liver. Decreased mRNA expression of Dgat2, the rate-limiting enzyme in triglyceride biosynthesis (Fig. 2f) , also suggested a lower rate of lipid synthesis in LCMV-infected mice 15 . Notably, inguinal fat pads in infected mice showed increased vascularization (see Supplementary Fig. 2b,c) , which may be involved in inflammation-mediated tissue remodeling. Together, these data show that LCMV clone 13 infection leads to depletion of lipid stores in adipose tissue by modulating key regulators of lipid metabolism.
To investigate whether the virus-induced adipose tissue wasting followed similar mechanisms to CAC, we examined the mRNA expression of Ucp1 as an indicator of adipose tissue beiging. The mRNA expression of Ucp1 was marginally lower in the interscapular, inguinal and gonadal fat of infected mice compared with pair-fed mice (Fig. 2g) during LCMV infection compared with the floxed control group ( Fig. 2h ), suggesting that neither lipase was required for IAC. The hormone ghrelin and adipokines such as leptin and adiponectin are considered active modulators of both metabolic and immune processes 11, 17, 18 . The amount of ghrelin in the serum and the expression of adiponectin in inguinal adipose tissue were similar in LCMV-infected and -uninfected mice (see Supplementary  Fig. 2d,f) . Notably, circulating leptin levels showed a reduction on LCMV infection, whereas mRNA expression of leptin was increased in inguinal adipose tissue at day 6 (see Supplementary Fig. 2e,f equally depleted in both groups (see Supplementary Fig. 2h ), suggesting that, although leptin expression was increased in the adipose tissue, it did not mediate the activated lipolytic state or the disrupted feeding behavior during LCMV infection. These results indicate that IAC triggers structural and metabolic reprogramming in adipose tissue between day 6 and day 8 post-infection.
Infection-associated cachexia is driven by type I IFN and CD8
+ T cells. In various models of cachexia and adipose tissue remodeling, cytokines such as IFN-γ, TNF and IL-6 trigger weight loss, acting either independently or together with other cytokines and immune cells 8 . Bead-based multiplex assays for 32 cytokines, as well as ELISA assays for IFN-α and IFN-β, revealed a highly dynamic pattern for serum cytokines and indicated the induction of IFN-γ, TNF, IL-6, IFN-α and IFN-β, among others, within the first 96 h after LCMV clone 13 infection of wild-type mice ( Fig. 3a and Supplementary  Fig. 2a and Supplementary Table 1 ). Cytokines implicated in CAC, such as IL-1β and leukemia inhibitory factor 8, 19 , showed no increase in the serum of LCMV-infected mice (see Supplementary Fig. 3a and Supplementary Table 1 ). Pathways associated with proinflammatory cytokines such as IFN-γ, TNF and IL-6 have been linked to CAC 8, 20 . Neutralization of IFN-γ, TNF and IL-6 by genetic ablation using Ifng
, Tnf
−/− and TnfrI −/− mice or antibody-mediated blockade initiated 1 day before infection, and then continued every second day, did not ameliorate weight loss in LCMV-infected mice (Fig. 3b,c) . Infected mice, in which we simultaneously depleted IFN-γ and TNF using neutralizing antibodies, still lost up to 20% of their body weight by day 8 post-infection (Fig. 3b) . Type 1 IFNs were detectable in the serum of LCMV-infected mice within the first 2 days of infection (Fig. 3a) 
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. Genetic ablation of IFN-α/β-receptor α chain (IFNAR) signaling using Ifnar1 −/− mice resulted in ameliorated weight loss by approximately 10% at 8 days after infection compared with wild-type LCMV-infected mice ( Fig. 3d and Supplementary Fig. 3b,c) , implicating type I IFN responses in IAC.
Next, we determined whether a particular T cell population mediated weight loss during LCMV infection. This was done through the intravenous injection of depleting antibodies for CD8 + T cells and CD4 + T cells 2 days and 1 day, respectively, before LCMV infection (Fig. 3e,f) or infection of Cd8 −/− mice (Fig. 3f) . The depletion of CD4 + T cells in LCMV-infected mice did not protect against weight loss ( Fig. 3e and Supplementary Fig. 3d-f) ; however, depletion of −/− mice (n = 4; ****P < 0.0001, two-way ANOVA). e, Mice treated with anti-CD4-depleting antibodies (n = 4). f, Cd8 −/− mice and mice treated with anti-CD8-depleting antibodies (n = 4;*P = 0.027, *P = 0.046, two-way ANOVA). c-f, These are representative of two independent experiments. The data show the mean ± s.e.m.
CD8
+ T cells resulted in little to no weight loss compared with wildtype controls ( Fig. 3f and Supplementary Fig. 3d-f) . These results suggested a key role for CD8 + T cells in IAC. To examine whether CD8 + T cells drove weight loss in other viral infections, we infected Rag2 −/− mice, which lack both T and B lymphocytes, with a sublethal dose of influenza virus strain PR/8. Although LCMV-infected Rag2 −/− mice were protected from weight loss (see Supplementary Fig. 3g ), PR/8-infected Rag2 −/− mice continued to lose weight after 8 days and infected wild-type mice started to regain weight (see Supplementary Fig. 3h ). These results indicated that weight loss during influenza virus infection occurs via different mechanisms compared with those mediating weight loss during LCMV infection. Uninfected wild-type mice fed the same amount of food as that consumed by PR/8-infected wild-type mice had identical weight loss to the infected group (see Supplementary  Fig. 3i,j) , suggesting that weight loss in PR/8-infected mice was due to anorexia. These findings highlight the variety of mechanisms by which weight loss occurs in different infection settings.
+ T cell-intrinsic IFNAR1 signaling alters lipid metabolism during infection. Supplementary Fig. 4a ), whereas the LCMV-infected Ifnar1 fl/fl Cd4 Cre/+ mice were protected from weight loss, and preserved both fat and lean mass (Fig. 4a,b + T cell in their spleens and inguinal lymph nodes (iLNs) at day 6 post-infection, the time point at which cachexia is initiated (see Supplementary Fig. 4b,c) Supplementary Fig. 4b,c) . Expansion of CD8 + T cells was impaired at day 8 after LCMV infection in the spleens of Ifnar1 fl/fl Cd4
Cre/+ compared with Ifnar1 flfl mice (data not shown), indicating that CD8 + T cell-intrinsic signaling through IFNAR was required for T cell activation and expansion 22, 23 . To gain further insights into the changes taking place in the adipose tissue of LCMV-infected mice, we performed RNA-sequencing (RNA-seq) analysis of bulk adipose tissue from inguinal fat pads of , during infection were involved in lipid metabolism (Fig. 4f) . The expression of genes involved in the biosynthesis and uptake of lipids was predominantly downregulated in adipose tissue of LCMV-infected Ifnar1 fl/fl compared with LCMV-infected Ifnar1 fl/fl Cd4 cre/+ mice (Fig. 4g) . Notably, the expression of Dgat2, the rate-limiting enzyme in triglyceride synthesis, showed the anticipated reduction of expression during infection in Ifnar1 fl/fl mice and this was absent in infected Ifnar1 fl/fl Cd4 cre/+ mice (Fig. 4g,h) . Similarly, Lpl expression decreased during infection but not in Ifnar1 fl/fl Cd4 cre/+ mice. Expression of Cd36 was not affected in any condition (Fig. 4h) .
Cd4
cre/+ mice compared with Ifnar1 fl/fl mice (Fig. 4i) . The lipolysis of adipose tissue is triggered by a variety of hormones and signaling molecules, such as glucocorticoids, which induce the expression of ATGL and HSL, thyroid-stimulating hormone and catecholamines; these all induce the phosphorylation of HSL by interacting with the thyroid-stimulating hormone receptor in the case of thyroid-stimulating hormone or with β-adrenergic receptors in the case of catecholamines 24 . Quantification of circulating cortisol and corticosterone, at day 6 after LCMV infection, indicated increased levels of cortisol and corticosterone in Ifnar1 flfl mice compared with uninfected Ifnar1 flfl mice, which was abrogated in Ifnar1 fl/fl
Cre/+ mice ( Fig. 4j and Supplementary  Fig. 4d ). Circulating amounts of free thyroxine and free triiodothyronine remained relatively constant across all conditions (see Supplementary Fig. 4d ). Furthermore, serum concentrations of norepinephrine were slightly reduced in Ifnar1 flfl mice on infection, but were increased in infected Ifnar1 fl/fl
cre/+ mice compared with uninfected mice at day 6 post-infection (see Supplementary  Fig. 4d ). The amounts of norepinephrine in the inguinal adipose tissue remained relatively constant throughout all conditions (see Supplementary Fig. 4d ). Downstream of these signaling hormones, expression of Abrd2 mRNA (encoding the β-adrenergic receptors) was highly increased in the inguinal fat of LCMV-infected compared with uninfected Ifnar1 flfl mice, as were protein levels of pHSL (see Supplementary Fig. 4d ). Both increases were abrogated in the inguinal fat of Ifnar1 fl/fl Cd4 cre/+ mice (see Supplementary Fig. 4d ), consistent with reduced lipolysis in these mice. Expression of ATGL was increased, and expression of the lipid droplet-associated protein, perilipin, was decreased similarly in LCMV-infected Ifnar1 fl/fl
Cre/+ and Ifnar1 fl/fl mice (see Supplementary Fig. 4d ). The hydrolytic activity of ATGL is controlled by its coactivator, CGI-58 (ref. 
cre/+ mice compared with uninfected mice (see Supplementary Fig. 4d ). These observations indicate that the correlation between the increased amounts of glucocorticoids in the serum and the upregulation of lipolysis in LCMV-infected mice was dependent on IFNAR signaling in CD8 + T cells.
CD8 + T cells trigger cachexia through antigen-specific activation. We next examined the kinetics of viral infection and T cell infiltration into the inguinal fat of LCMV-infected mice. Using immunofluorescent co-staining for the LCMV nucleoprotein (NP)
+
and CD8
+ T cells, we detected the presence of viral nucleoprotein and CD8
+ cells at day 6 and day 8 post-infection (Fig. 5a,b) , consistent with the detection of LCMV-NP mRNA by quantitative PCR from inguinal, gonadal and brown adipose tissue of infected wild-type mice (see Supplementary Fig. 1c) . To address the role of T cell infiltration into adipose tissue, we treated infected and control mice with the immunosuppressive drug FTY720, which transiently blocks the egress of lymphocytes from the lymphoid organs without interfering with T cell priming 25 . Flow cytometry indicated a reduction of virus-specific GP33 + and NP396 + CD8 + T cells in the blood and spleen of FTY720-treated mice, and their accumulation in iLNs ( Fig. 5c and Supplementary Fig. 5a-d) . Treatment with FTY720 did not affect weight loss in infected mice compared with sham-treated mice (Fig. 5d) , suggesting no role or only a minor role of local T cell infiltration in triggering adipose tissue wasting. In line with this, LCMV-infected Prf1 −/− mice, which lack perforin, an important mediator of cytotoxic activity in CD8 + T cells, had similar weight loss kinetics to the infected wild-type mice (Fig. 5e) , suggesting that CD8 + T cells triggered cachexia independently of cytotoxic cell-tocell interaction.
To address whether CD8 + T cells trigger adipose tissue wasting as a result of direct antigen stimulation, or in response to bystander activation induced by the inflammatory milieu, we generated mixed bone marrow chimeras. This was done using wild-type (CD45. −/− mice. After confirming the success of the bone marrow reconstitution using congenic markers (see Supplementary Fig. 5e-f . Data show PCA (c), number of modulated genes (d) and significantly modulated genes (< 0.05 adjusted P, log-fold-change > 0.7 or < −0.7) in the limma implementation of the 2 × 2 factorial interaction model. e, The top five enriched ClueGo pathways for up-and downregulated genes. f, Enrichment of top 10 modulated metabolic pathways. DAG, diacylgylcerol; TAG, triacylglycerol. g, Heatmap of the top modulated genes involved in lipid biosynthesis, uptake, or breakdown and release. h, RNA expression of Cd36, Lpl and Dgat2 (****P < 0.0001, *P = 0.015, two-way ANOVA, Bonferroni's correction). i, Serum triglyceride and NEFA levels (n = 4; **P = 0.0027, ***P = 0.0004, two-way ANOVA). j, Circulating levels of cortisol and corticosterone, as measured by ELISA (n = 4; **P = 0.0010, *P = 0.0185, ***P = 0.0001, ***P = 0.0004, two-way ANOVA, Bonferroni's correction). h-j, The data are representative of two independent experiments and show the mean ± s.e.m.
LCMV-specific, CD8
+ GP33 + T cells in the spleens of OT-I Rag1 −/− + Cd8 −/− mice compared with wild-type + Cd8 −/− controls (see Supplementary Fig. 5g,h ).
OT-I Rag1
−/− + Cd8 −/− chimeric mice were completely protected against LCMV-induced weight loss, whereas the wild-type + Cd8 −/− chimeric mice lost approximately 20% of their body weight (Fig. 5f,g ), indicating that antigen-specific priming of CD8 + T cells was required for LCMV-induced weight loss. Together, these data suggest that CD8 T cells triggered weight loss during the early stages of activation, following antigen-specific stimulation, and is likely to occur independent of direct cell-to-cell interaction.
Discussion
In the present study we employed a model of chronic viral infection to elucidate the inflammatory drivers of IAC.
IAC manifested 6 days after infection, preceding the peak of the adaptive immune response at day 12, then showed gradual resolution thereafter, which contrasts with the terminal course of CAC 3, 5 . We reported in the present study on a role for type I IFNs and CD8 + T cells in triggering IAC, but not IL-6, TNF and IFN-γ, cytokines that often mediate CAC 6, 8 . The manifestation of IAC required IFNAR1 signaling specifically within T cells not adipocytes, in addition to antigen-specific CD8 + T cell receptor priming. Deletion of the cytolytic effector molecule perforin or the pharmacologic blockade of T cell egress from lymphatic organs did not prevent cachexia, which suggested mechanisms other than classic CD8
+ T cell-mediated cytotoxicity.
During CAC, adipose lipid storage is depleted through increased ATGL-and HSL-mediated lipolysis, resulting in elevated circulating NEFAs, a process that we also observed during LCMV-induced cachexia 14, 15 . In contrast to CAC, however, we did not observe increased adipose tissue beiging and thermogenesis 26, 27 . We found a depletion of inguinal, gonadal and brown adipose tissue, accom- panied by increased vascular density at 6 and 8 days post-infection, mainly in the inguinal compartment. Such remodeling may facilitate nutrient shuttling from the adipose tissue and modulate its exposure to metabolic and/or hormonal regulators, which could further amplify its depletion. Increased vascularization is one of several similar features between IAC and obesity 28 , all of which could further influence systemic inflammation, dyslipidemia and metabolic dysfunctions across different organs 29 .
Expression of leptin, a key regulator of appetite, lipolysis and the immune response 17 , showed a marked increase in adipose tissue of infected mice. However, the genetic ablation of leptin in Lep ob/ob did not prevent weight loss and anorexia during LCMV infection. We observed a correlation between increased lipolysis and the increased circulating glucocorticoids, which are central drivers of the stressresponse program, and can induce lipolysis by activating ATGL and HSL 24 . In addition, glucocorticoids have endogenous roles in regulating systemic metabolism and are well-known immunomodulatory molecules [30] [31] [32] , which situates them as potential candidates in mediating immunometabolic crosstalk during IAC.
Previous studies examining LCMV-associated morbidity used intracranial infection with LCMV Armstrong, and reported weight loss that occurred as a direct result of anorexia mediated by major histocompatibility complex-II-restricted CD4 + T cells [33] [34] [35] , which contrasts the weight loss independent of the anorexia observed in our model. In the present study force feeding the mice during LCMV infection, or the supplementation with specific nutrients, did not alleviate weight loss, but rather hampered recovery, particularly on administration of glucose and casein. This is contrary to observations during infection with the influenza virus or injection of poly(I:C), in which administration of glucose and casein improved survival 36 . These differences may be due to distinct metabolic demands during different infections, influenced by viral life cycle, tropism and/or virus-induced immune responses, leading to either anorexia or cachexia. In line with this, Rag2 −/− mice were not protected from weight loss during influenza infection. The detrimental effects of nutrient supplementation suggest that fasting metabolism is advantageous for efficient recovery. Fasting metabolism and caloric restriction had positive effects on survival and immune function in other models of bacterial infection and cancer 36, 37 , and may have beneficial effects for cancer patients 38, 39 . The underlying mechanisms of nutrient redistribution during fasting in IAC and CAC warrant further investigations. CD8 + T cells are drivers of immunopathology in chronic infections such as LCMV and human immunodeficiency virus 40 . Studies have shown that virus clearance or persistence is determined during the early phase of infection, although the exact mechanisms are not well understood 12, 41, 42 . We speculate that the onset of cachexia during the early stages of infection with LCMV clone 13 may be linked to the establishment of viral persistence. To this point, mice infected with either the acute Armstrong strain of LCMV or with low doses of LCMV clone 13 did not show weight loss. These observations raise the question of the potential evolutionary advantages of cachexia. As a result of the correlation between cachexia and worsened prognosis in cancer patients, the syndrome has been presumed to be detrimental 7 . However, this assumption lacks a thorough mechanistic foundation and remains a matter of debate 43 . In infection, cachexia could serve an immunomodulatory role by tempering the immune response to limit immunopathology, similar to T cell exhaustion 44 . Alternatively, cachexia could facilitate a rapid increase of nutrient accessibility to fuel adaptive immune responses and/or other inflammatory processes. This would explain the excessive release of NEFAs at day 6 post-infection, a time point when energy metabolism shifts toward fat use. At the present time, relatively little is known about the regulation of nutrient redistribution across organs in inflammatory conditions, and how that may influence the immune response, metabolism and tissue repair 45 .
The present study contributes to understanding the mechanisms that induce cachexia in different inflammatory and disease settings. Studies of cachexia and its context-dependent pathogenesis can improve the understanding of pathophysiological processes and systemic immunometabolism 46, 47 . Comparative studies in infection and cancer could provide invaluable insights into the pathogenesis of cachexia and possible new therapeutic strategies.
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Experimental model and subject details. Mice. In the present study we used both wild-type and genetically modified mouse models, all on a C57BL/6 background. These mice were bred under specific pathogen-free conditions at the Institute for Within each experiment, mice were both age and sex matched; however, male and female mice were used interchangeably between experiments, and results showed no sex-dependent differences in any of the measured parameters. To generate chimeric mice, bone marrow cells were isolated from donor mice by flushing the femur and tibia with 10% FCS, β-mercaptoethanol, 1% penicillinstreptomycin and 2 mM l-glutamine. Cells were ran through a strainer, centrifuged and then frozen in 10% DMSO, 75% FCS and 15% media, consisting of RPMI (10% FCS, β-mercaptoethanol, 1% penicillin-streptomycin and 2 mM l-glutamine). The cells were then stored at −80 °C until transfer. Recipient mice were subjected to 10.5 Gy irradiation using BIOBEAM GM 2000 (Gamma Medical Services); 1 day post-irradiation, mice received 1 × 10 7 cells from donor mice in a 1:1 ratio. Mice were then allowed a period of recovery, before receiving two rounds of 200 μg of anti-CD90 treatment. To examine the efficiency of the procedure, we performed FACS analysis of a CD45.1:CD45.2 ratio.
Virus. C57BL/6 mice were infected intravenously with high-dose (2 × 10 6 FFU) LCMV strain clone 13, except when indicated otherwise. For the dose titration experiment, the virus was titrated by a factor of 10 to get the following inocula: 2 × 10 6 FFU, 2 × 10 5 FFU, 2 × 10 4 FFU, 2 × 10 3 FFU and 2 × 10 2 FFU. For acute LCMV infection, mice were infected with high-dose 2 × 10 6 FFU of LCMV strain Armstrong. Viral loads were determined using a focal-forming assay Mouse calorimetry. Mice were individually placed in the PhenoMaster (TSE Systems) cages 2 days before infection and allowed to acclimatize to the new environment. After infection, metabolic parameters such as food and water intake, oxygen consumption, carbon dioxide production, RER and activity were measured every 12 min (5 measurements every hour) for 12 consecutive days.
Feeding experiments. During pair-feeding experiments, all mice were placed in single housing for a minimum of 3 days before the start of the experiment, and monitored daily throughout the course of the experiment. Each day the food intake of LCMV-infected mice was measured (ad libitum diet), and a matching amount was given to the pair-fed control mice (restricted diet) up to the point of harvest. For gavage feeding experiments, mice were weighed before infection and, subsequently, infected at the same time. The gavage took place starting from 4 days until 7 days post-infection with continuous free access to a chow diet. During the gavage period mice received 0.5 ml of either PBS or a respective diet twice a day, constituting a supplementation of 1 kcal day -1
. Abbot Promote-high protein diet
(1 kcal ml -1 ) was used as the control diet due to the high compatibility with the nutritional profile of chow diet (Abbot Promote, calorie composition: 25% protein, 23% fat and 52% carbohydrates; chow diet, calorie composition: 24% protein, 18% fat and 58% carbohydrates) 36 .
Antibodies and pharmacologic treatments. The antibodies used were: Rat IgG1 isotype (MOPC-21, BE0083-BioXcell), Hamster IgG1 isotype (BE0091-BioXcell), anti-TNF-α (XT3.11, Rat IgG1, BE0058-BioXcell), anti-IFN-γ (XMG1.2, Rat IgG1, BE0055-BioXcell), anti-IL-1α (ALF-161, Hamster IgG1, BE0243-BioXcell), anti-IL-6 (MP5-20F3, Rat IgG1, BE0046-BioXcell), anti-CD4 (YTS191, Rat IgG2b, BE0119-BioXcell), anti-CD8 (YTS169.4, Rat IgG2b, BE0117-BioXcell) and anti-CD90 (T24, Rat IgG2b, BE0212-BioXcell). Anti-IFN-γ, anti-TNF-α, anti-IL-6 neutralizing antibodies (0.5 mg), and their Rat IgG1 isotype control, were intraperitoneally injected 1 day before LCMV infection, and were re-administered every second day up to 7 days post-infection. For anti-IL-1α, and its Hamster IgG1 isotype control, 0.2 mg was intraperitoneally injected every 3 days, starting 2 days before LCMV infection. For antibody depletion of CD4 and CD8 T cells, 0.2 mg of monoclonal antibodies was injected iintravenously 2 days and 1 day before infection. FACS analysis was performed on blood to confirm the efficiency to CD4 + and CD8 + T cell depletion. FTY720 administration was performed as described in a previous paper 25 .
Mice received a daily gavage of 0.3 mg kg -1 of FTY720 (SML0700, Sigma-Aldrich) dissolved in sterile water. The treatment was administered 1 day before infection and carried on until 8 days post-infection. Blood samples were drawn at 6 and 8 days post-infection, and mice were scarified at 8 days post-infection via cervical dislocation. Spleen and iLNs were subsequently taken for FACS analysis.
Imaging. We used the EchoMRI-100H (EchoMRI LCC) to longitudinally monitor body composition in a non-invasive manner in awake un-anesthetized mice. The results displayed show the average of three consecutive measurements for each mouse within an experimental group, during each time point. For magnetic resonance imaging (MRI), mice were euthanized using cervical dislocation before imaging and kept at 4 °C until imaged. MRI measurements were performed on a 9.4 T animal MRI (BioSpec 94/30USR Bruker Biospin) equipped with a B-GA12SHP gradient and an 1 H volume coil with an inner diameter of 40 mm (RFRES 400 1 H 075/040 QSN TR, Bruker Biospin). A multi-spin echo sequence (repetition time = 500 ms, echo time = 7.86 ms, average = 4) was used, with and without fat suppression (fat suppression bandwidth = 1401.17 Hz). A set of 24 slices was acquired in a coronal direction with a resolution of 100 μm 2 in plain and a slice thickness of 1 mm. Total acquisition time was 16 min. To evaluate the size of the fat compartments, the fat-suppressed images are subtracted from corresponding images without fat suppression. Postprocessing was performed using ParaVision v.6 (Bruker Biospin).
Histology. Mice were anesthetized using 15% ketamine and 5% xylazine in PBS, and then perfused with 20 ml of 4% paraformaldehyde in PBS. Isolated tissue was then incubated in 4% paraformaldehyde in PBS, before being transferred to PBS.
For H&E staining, histologic evaluation was performed on 3-μm-thick sections stained with H&E. Four to five representative images (20× magnification) were collected from each fat pad for quantitative analysis using ImageJ-Adiposoft plugin. Cutoffs were set to include all cells larger than 10 μm and smaller than 100 μm in diameter. Images were run through the automated Adiposoft analysis and then manually adjusted as needed.
For immunofluorescence staining, heat-induced antigen retrieval (citrate buffer, pH 6) and unspecific binding blocking (FCS block plus goat anti-mouse Fab block) was performed on paraformaldehyde-fixed sections. Sections were subsequently incubated with the following primary antibodies: rabbit anti-LCMV nucleoprotein sera (1:4,000, generated by prime-boost immunization against purified LCMV-NP) and rat anti-CD8a (1:1000, eBioscience, no. 4SM15) diluted in DAKO Real Antibody Diluent (no. S2022). Bound antibodies were visualized with appropriate species-specific Alexa Fluor 647 anti-rat and Alexa Fluor 488 antirabbit (1:200, Jackson ImmunoResearch). Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; 1:2,000, Invitrogen). Immunostained sections were scanned using a Pannoramic 250 FLASH II (3DHISTECH) Digital Slide Scanner with objective magnification of 20×. Four to five representative images were captured at 20× magnification and the image analysis was done using Cell Profiler v.3.0.
Serum measures. Blood samples were collected via the tail vein for longitudinal measurements. For end-point measurements, animals were anesthetized using 15% ketamine and 5% xylazine in PBS, blood was immediately drawn from the vena cava, and the animals where then euthanized via cervical dislocation. Triglyceride levels in the serum were determined using a Cobas C311 Analyzer (Roche). The NEFA content was evaluated enzymatically using NEFA kit (Wako Chemicals: reagents: 434-91795, standard 270-77000).
We used the MILLIPLEX MAP Mouse Cytokine/Chemokine Magnetic Bead Panel-Premixed 32 Plex (MCYTMAG-70K-PX32, Millipore) to quantify a wide range of circulating cytokines and chemokines. Analysis was done following the manufacturer's instructions. To detect circulating levels of IFN-α, we performed ELISA using rat anti-mIFN-α capture antibody (PBL Interferon Source,
